Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy-Reference-Cited by-同舟云学术

Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy

Published:2006-03 Issue:1 Volume:11 Page:53-60
ISSN:1085-9489
Container-title:Journal of the Peripheral Nervous System
language:en
Short-container-title:J Peripher Nerv Syst

Author:

Comi Cristoforo,Gaviani Paola,Leone Maurizio,Ferretti Massimo,Castelli Luca,Mesturini Riccardo,Ubezio Gianluca,Chiocchetti Annalisa,Osio Maurizio,Muscia Francesco,Bogliun Graziella,Corso Giovanni,Gavazzi Armando,Mariani Claudio,Cantello Roberto,Monaco Francesco,Dianzani Umberto

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1085-9489.2006.00063.x/fullpdf

Reference24 articles.

1. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP)

2. Loss of Phosphatase Activity in Myotubularin-related Protein 2 is Associated with Charcot-marie-tooth Disease Type 4B1

3. T-cell cytotoxicity of human Schwann cells: TNF? promotes fasL-mediated apoptosis and IFN? perforin-mediated lysis

4. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy

5. Defective T cell Fas function in patients with multiple sclerosis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased Expression of CD95 in CD4+ Effector Memory T Cells Promotes Th17 Response in Patients with Myasthenia Gravis;Journal of Neuroimmune Pharmacology;2021-10-29

2. Differences in Thyroid Function and Autoantibodies in the Development of Guillain–Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy;Frontiers in Neurology;2020-09-10

3. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes;Journal of the Neurological Sciences;2016-06

4. Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy;Immunotherapy;2016-02

5. Low and high doses of ursolic acid ameliorate experimental autoimmune myasthenia gravis through different pathways;Journal of Neuroimmunology;2015-04